Literature DB >> 30770916

B cells in Sjögren's syndrome: from pathophysiology to therapeutic target.

Julie Mielle1, Alice Tison2,3, Divi Cornec2,3, Laëtitia Le Pottier2, Claire Daien1, Jacques-Olivier Pers2.   

Abstract

Biological abnormalities associated with B lymphocytes are a hallmark of patients with primary Sjögren's syndrome. Those patients present abnormal distribution of B lymphocytes in peripheral blood and B cells in exocrine glands. B cells produce auto-antibodies, cytokines and present antigens but can also suppressive functions. In this review, we will summarize current knowledge on B cells in primary Sjögren's syndrome patients, demonstrate their critical role in the immunopathology of the disease and describe the past and current trials targeting B cells.
© The Author(s) 2019. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  B cells; BAFF; autoreactivity; cytokines; ectopic germinal centers; epigenetics; immunotherapy; lymphoma; primary Sjögren’s syndrome; regulation

Year:  2019        PMID: 30770916     DOI: 10.1093/rheumatology/key332

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  9 in total

1.  Identification of immune-related diagnostic markers in primary Sjögren's syndrome based on bioinformatics analysis.

Authors:  Qingle Zeng; Jing Wen; Leting Zheng; Wen Zeng; Shuyuan Chen; Cheng Zhao
Journal:  Ann Transl Med       Date:  2022-04

2.  Elevated expression of BAFF receptor, BR3, on monocytes correlates with B cell activation and clinical features of patients with primary Sjögren's syndrome.

Authors:  Keiko Yoshimoto; Katsuya Suzuki; Eriko Takei; Yumi Ikeda; Tsutomu Takeuchi
Journal:  Arthritis Res Ther       Date:  2020-06-23       Impact factor: 5.156

Review 3.  What is the evidence that mycobacteria are associated with the pathogenesis of Sjogren's syndrome?

Authors:  Coad Thomas Dow; Edward D Chan
Journal:  J Transl Autoimmun       Date:  2021-02-05

Review 4.  Innate Immunity and Biological Therapies for the Treatment of Sjögren's Syndrome.

Authors:  Amrita Srivastava; Helen P Makarenkova
Journal:  Int J Mol Sci       Date:  2020-12-01       Impact factor: 5.923

5.  Autoimmune B Cell Repertoire in a Mouse Model of Sjögren's Syndrome.

Authors:  Manuel Sáez Moya; Rebeca Gutiérrez-Cózar; Joan Puñet-Ortiz; María Luisa Rodríguez de la Concepción; Julià Blanco; Jorge Carrillo; Pablo Engel
Journal:  Front Immunol       Date:  2021-04-23       Impact factor: 7.561

Review 6.  Metabolic Program of Regulatory B Lymphocytes and Influence in the Control of Malignant and Autoimmune Situations.

Authors:  Cristian Iperi; Anne Bordron; Maryvonne Dueymes; Jacques-Olivier Pers; Christophe Jamin
Journal:  Front Immunol       Date:  2021-09-28       Impact factor: 7.561

7.  P2Y2 receptor antagonism resolves sialadenitis and improves salivary flow in a Sjögren's syndrome mouse model.

Authors:  Kimberly J Jasmer; Lucas T Woods; Kevin Muñoz Forti; Adam L Martin; Jean M Camden; Marco Colonna; Gary A Weisman
Journal:  Arch Oral Biol       Date:  2021-02-03       Impact factor: 2.633

Review 8.  Recent advances in the search for a targeted immunomodulatory therapy for primary Sjögren's syndrome.

Authors:  David L Leverenz; E William St Clair
Journal:  F1000Res       Date:  2019-08-29

Review 9.  Biological Therapy in Primary Sjögren's Syndrome: Effect on Salivary Gland Function and Inflammation.

Authors:  Farzana Chowdhury; Anwar Tappuni; Michele Bombardieri
Journal:  Front Med (Lausanne)       Date:  2021-07-15
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.